Utilizing Machine Learning to Determine Risk Factors for Hospital-Acquired Infections in Cancer Patients Experiencing Pneumonia Related to Immune Checkpoint Inhibitors - Takeaways - MDSpire

Utilizing Machine Learning to Determine Risk Factors for Hospital-Acquired Infections in Cancer Patients Experiencing Pneumonia Related to Immune Checkpoint Inhibitors

  • By

  • Jianzhong Xie

  • Zhuo Zhao

  • Cuiyun Zhou

  • Junxiang Wang

  • Xiufang Lin

  • Lingyu Lai

  • Jinchan Yao

  • Haiyan Lin

  • Zuquan Weng

  • January 29, 2026

  • 0 min

Share

  • 1

    PD-1/PD-L1 inhibitors can cause immune-related pneumonia, with an incidence of 0% to 10%, necessitating careful monitoring for hospital-acquired infections.

  • 2

    Machine learning can analyze extensive patient data to create early warning models for nosocomial infections in cancer patients receiving immunotherapy.

  • 3

    In a study of 120 patients, the overall incidence rate of nosocomial infection was found to be 45.83%, with pulmonary infections being the most common.

  • 4

    Significant risk factors for nosocomial infections included diagnosis time and elevated CRP levels, highlighting the need for targeted infection management.

  • 5

    The support vector machine model outperformed others in predicting infections, identifying key risk factors such as age and abnormal lung function.

Original Source(s)

Utilizing Machine Learning to Determine Risk Factors for Hospital-Acquired Infections in Cancer Patients Experiencing Pneumonia Related to Immune Checkpoint Inhibitors

  • by Jianzhong Xie, Zhuo Zhao, Cuiyun Zhou, Junxiang Wang, Xiufang Lin, Lingyu Lai, Jinchan Yao, Haiyan Lin, Zuquan Weng

  • January 29, 2026

Related Content

Real-world treatment patterns and outcomes for patients with extensive-stage small-cell lung cancer treated in US community oncology practices

7 Days Noninferior in Bacteremia

BALANCE compared 7 vs 14 days of treatment among hospitalized patients with bloodstream infections.

Clinical characteristics and risk factors of necrotizing pneumonia secondary to severe pneumonia in children